• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲核芳香取代反应能够通过非阻转异构体中间体实现杂环阻转异构体的多样性导向合成。

Nucleophilic aromatic substitutions enable diversity-oriented synthesis of heterocyclic atropisomers via non-atropisomeric intermediates.

作者信息

Šimek Michal, Dey Paritosh, Blahout Vilém, Mondal Krishanu, Ernenwein Jeanne, Dračínský Martin, Bím Daniel, Paioti Paulo H S

机构信息

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.

Department of Organic Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.

出版信息

Nat Commun. 2025 May 25;16(1):4856. doi: 10.1038/s41467-025-60101-z.

DOI:10.1038/s41467-025-60101-z
PMID:40414917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12104334/
Abstract

Atropisomers are sterically hindered molecules whose formation typically proceeds via atropisomeric intermediates and encumbered transition states. It is therefore largely accepted that the activation energy is higher for synthesis of atropisomers than for synthesis of similar, less sterically congested non-atropisomeric compounds. Here we show that atropisomer formation by nucleophilic aromatic substitution (SAr) reactions can progress via non-atropisomeric intermediates and transition states. We put forth fast, mild, practical, regio- and chemoselective SAr reactions that generate a diverse array of difficult-to-access heterobiaryl C─N atropisomers starting with readily available N─H heterocycles and aryl fluorides, as well as two catalytic methods employing N─SiR and N─H heterocycles for synthesis of title atropisomers in seconds. Products of SAr are readily diversifiable, streamlining access to countless drug-like C─N atropisomers, including macrocycles, peptides, and analogs of achiral heterobiaryl pharmaceuticals. Supported by experimental and computational data, we discuss how steric repulsion is minimized in stereogenic axis-forming SAr processes.

摘要

阻转异构体是空间位阻较大的分子,其形成通常通过阻转异构中间体和受阻过渡态进行。因此,人们普遍认为,合成阻转异构体的活化能高于合成类似的、空间位阻较小的非阻转异构化合物。在此,我们表明,通过亲核芳香取代(SAr)反应形成阻转异构体可以通过非阻转异构中间体和过渡态进行。我们提出了快速、温和、实用、区域和化学选择性的SAr反应,这些反应从容易获得的N-H杂环和芳基氟化物开始,生成各种难以获得的杂联芳基C-N阻转异构体,以及两种使用N-SiR和N-H杂环的催化方法,可在数秒内合成标题阻转异构体。SAr反应的产物易于多样化,简化了获得无数类药物C-N阻转异构体的途径,包括大环化合物、肽以及非手性杂联芳基药物的类似物。在实验和计算数据的支持下,我们讨论了在形成立体轴的SAr过程中如何将空间排斥最小化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/1568a2ba1188/41467_2025_60101_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/629f01452566/41467_2025_60101_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/630318f8f90b/41467_2025_60101_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/4d0390552827/41467_2025_60101_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/cad0f1768ee3/41467_2025_60101_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/37b6e713503a/41467_2025_60101_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/ca5558819441/41467_2025_60101_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/1568a2ba1188/41467_2025_60101_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/629f01452566/41467_2025_60101_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/630318f8f90b/41467_2025_60101_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/4d0390552827/41467_2025_60101_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/cad0f1768ee3/41467_2025_60101_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/37b6e713503a/41467_2025_60101_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/ca5558819441/41467_2025_60101_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/817e/12104334/1568a2ba1188/41467_2025_60101_Fig7_HTML.jpg

相似文献

1
Nucleophilic aromatic substitutions enable diversity-oriented synthesis of heterocyclic atropisomers via non-atropisomeric intermediates.亲核芳香取代反应能够通过非阻转异构体中间体实现杂环阻转异构体的多样性导向合成。
Nat Commun. 2025 May 25;16(1):4856. doi: 10.1038/s41467-025-60101-z.
2
Catalytic Asymmetric Synthesis of Atropisomers Featuring an Aza Axis.基于氮杂轴的阻转异构体的催化不对称合成
Acc Chem Res. 2023 Sep 19;56(18):2537-2554. doi: 10.1021/acs.accounts.3c00419. Epub 2023 Sep 11.
3
Nucleophilic Aromatic Substitution of Halobenzenes and Phenols with Catalysis by Arenophilic π Acids.卤代苯和苯酚在亲芳性π酸催化下的亲核芳香取代反应
Acc Chem Res. 2024 Aug 6;57(15):2194-2206. doi: 10.1021/acs.accounts.4c00327. Epub 2024 Jul 23.
4
Biocatalytic Enantioselective Synthesis of Atropisomers.生物催化对映异构体的立体选择性合成。
Acc Chem Res. 2022 Dec 6;55(23):3362-3375. doi: 10.1021/acs.accounts.2c00572. Epub 2022 Nov 7.
5
Enantioselective Synthesis of Atropisomers via Vinylidene -Quinone Methides (VQMs).通过亚乙烯基-醌甲醚(VQMs)对映选择性合成非对映异构体。
Acc Chem Res. 2022 Oct 4;55(19):2780-2795. doi: 10.1021/acs.accounts.2c00486. Epub 2022 Sep 19.
6
Enantioselective Synthesis of Atropisomeric Anilides via Pd(II)-Catalyzed Asymmetric C-H Olefination.通过 Pd(II)催化的不对称 C-H 烯丙基化反应对映选择性合成非对映异构体苯胺。
J Am Chem Soc. 2020 Oct 21;142(42):18266-18276. doi: 10.1021/jacs.0c09400. Epub 2020 Oct 8.
7
Atropisomerism in Drug Discovery: A Medicinal Chemistry Perspective Inspired by Atropisomeric Class I PI3K Inhibitors.手性药物发现中的对映异构体现象:受手性 Class I PI3K 抑制剂启发的药物化学观点。
Acc Chem Res. 2022 Sep 20;55(18):2581-2593. doi: 10.1021/acs.accounts.2c00485. Epub 2022 Sep 7.
8
Aryne Atropisomers: Chiral Arynes for the Enantiospecific Synthesis of Atropisomers and Nanographene Atropisomers.轴手性芳炔异构体:手性芳炔用于轴手性化合物和纳米石墨烯轴手性化合物的对映选择性合成。
Acc Chem Res. 2023 Jan 17;56(2):86-94. doi: 10.1021/acs.accounts.2c00575. Epub 2023 Jan 3.
9
Diversity-orientated synthesis of macrocyclic heterocycles using a double SAr approach.使用双 SAr 方法进行大环杂环的多样性导向合成。
Org Biomol Chem. 2021 Jul 21;19(28):6274-6290. doi: 10.1039/d1ob00612f.
10
Construction of Non-Biaryl Atropisomeric Amide Scaffolds Bearing a C-N Axis via Enantioselective Catalysis.通过对映选择性催化构建具有 C-N 轴的非联苯非对映异构体酰胺骨架。
Molecules. 2022 Oct 4;27(19):6583. doi: 10.3390/molecules27196583.

本文引用的文献

1
Catalytic Concerted SAr Reactions of Fluoroarenes by an Organic Superbase.有机超强碱催化氟代芳烃的协同SAr反应
J Am Chem Soc. 2024 Nov 27;146(47):32452-32462. doi: 10.1021/jacs.4c09042. Epub 2024 Nov 8.
2
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3-1,2,4-triazole-3-thione.在包含2-甲基-4-苯基-2,4-二氢-3H-1,2,4-三唑-3-硫酮的半乳糖基单糖半乳糖凝集素-3抑制剂中观察到的阻转异构现象。
J Med Chem. 2024 Aug 22;67(16):14184-14199. doi: 10.1021/acs.jmedchem.4c01008. Epub 2024 Aug 5.
3
Atroposelective Total Synthesis of Cihunamide B.
西胡酰胺B的对映选择性全合成
J Am Chem Soc. 2024 Jan 31;146(4):2549-2555. doi: 10.1021/jacs.3c11016. Epub 2024 Jan 19.
4
Atroposelective Chan-Evans-Lam Amination.位选择性的Chan-Evans-Lam胺化反应。
Chemistry. 2024 Mar 15;30(16):e202304378. doi: 10.1002/chem.202304378. Epub 2024 Jan 23.
5
First atroposelective Chan-Lam coupling for the synthesis of C-N linked biaryls.首例用于合成C-N键联联芳基化合物的对映选择性Chan-Lam偶联反应。
Chem Commun (Camb). 2024 Jan 16;60(6):678-681. doi: 10.1039/d3cc05447k.
6
Enantioselective organocatalytic synthesis of axially chiral aldehyde-containing styrenes via SAr reaction-guided dynamic kinetic resolution.通过SAr反应引导的动态动力学拆分对映选择性有机催化合成含轴手性醛基的苯乙烯类化合物。
Nat Commun. 2023 Aug 19;14(1):5050. doi: 10.1038/s41467-023-40840-7.
7
Discovery and Biosynthesis of Cihunamides, Macrocyclic Antibacterial RiPPs with a Unique C-N Linkage Formed by CYP450 Catalysis.西胡纳酰胺类化合物的发现与生物合成:一种由 CYP450 催化形成的具有独特 C-N 键连接方式的大环抗菌 RiPPs
Angew Chem Int Ed Engl. 2023 Jun 26;62(26):e202300998. doi: 10.1002/anie.202300998. Epub 2023 May 12.
8
Addressing Atropisomerism in the Development of Sotorasib, a Covalent Inhibitor of KRAS G12C: Structural, Analytical, and Synthetic Considerations.解决 Sotorasib(一种 KRAS G12C 的共价抑制剂)中立体异构现象的问题:结构、分析和合成方面的考虑。
Acc Chem Res. 2022 Oct 18;55(20):2892-2903. doi: 10.1021/acs.accounts.2c00479. Epub 2022 Sep 30.
9
Atropisomerism in the Pharmaceutically Relevant Realm.手性在药物相关领域的研究进展。
Acc Chem Res. 2022 Oct 18;55(20):2904-2919. doi: 10.1021/acs.accounts.2c00500. Epub 2022 Sep 26.
10
Atropopeptides are a Novel Family of Ribosomally Synthesized and Posttranslationally Modified Peptides with a Complex Molecular Shape.阿托肽是一类新型的核糖体合成和翻译后修饰的肽,具有复杂的分子形状。
Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202208361. doi: 10.1002/anie.202208361. Epub 2022 Sep 7.